FRANKFORT, Ky. — Representative Kim Moser’s legislation establishing the Kentucky Center for Cannabis Research unanimously passed the House floor on March 17. The measure, HB 604, sets the commission to study the use of cannabis and cannabis derivatives for treating certain medical conditions and diseases.
The commission will be operated at the University of Kentucky, which has already completed clinical research and has a strong connection to the Federal Drug Administration. The bill also establishes a clinical research participant application form for individuals interested in participating in clinical cannabis research and requires the center to apply for approval from the U.S. Drug Enforcement Administration (DEA) to cultivate cannabis.
“This convenes researchers and scholars from across the state on this issue so we can reduce bottlenecks in the research and regulatory processes,” said Moser, who represents parts of Kenton County. “Our goal is to figure out what conditions cannabis can treat, and by doing so, make Kentucky a national leader in research, since only one other university has a similar program.”
Currently, the University of Mississippi is the only federally authorized manufacturer of cannabis for all federally-approved cannabis research in the United States. The DEA released a final rule which seeks to expand the number of authorized growers in 2020.
Click here for more Kentucky business news.